Evaluation of High Resolution Melting analysis as an alternate tool to screen for risk alleles associated with small kidneys in Indian newborns.
BACKGROUND
Single nucleotide polymorphisms (SNPs) are the most common forms of sequence variations in the human genome. They contribute to the human phenotypic spectrum and are associated with variations in response to pathogens, drugs and vaccines. Recently, SNPs in three human genes involved in kidney development (RET, PAX2 and ALDH1A2) have been reported to be associated with variation in renal size and function. These known SNPs could potentially be used in the clinic as markers for identifying babies who may have smaller kidneys and permit close follow up for early detection of hypertension and acquired renal dysfunction. The aim of this study was to evaluate the use of High Resolution Melting technique (HRM) as a tool for detecting the known SNPs in these three genes in comparison to sequencing which is the gold standard.


METHODS
High resolution melting analysis was performed on 75 DNA samples that were previously sequenced for the known polymorphisms in RET (rs1800860), PAX2 (rs11190688) and ALDH1A2 (rs7169289) genes. The SNPs were G > A transitions in RET and PAX2 and A > G in ALDH1A2 gene. A blinded assessment was performed on these samples for evaluation of the HRM technique as compared to sequencing.


RESULTS
Each variant had a unique melt curve profile that was reproducible. The shift in melting temperature (Tm) allowed visual discrimination between the homozygous alleles (major and minor) in all three genes. The shape of the melting curve as compared to the major allele homozygous curve allowed the identification of the heterozygotes in each of the three SNPs. For validation, HRM was performed on 25 samples for each of the three SNPs. The results were compared with the sequencing results and 100% correct identification of the samples was obtained for RET, PAX2, and ALDA1H2 gene.


CONCLUSIONS
High Resolution Melting analysis is a simple, rapid and cost effective technique that could be used in a large population to identify babies with the risk alleles. These high risk children could be followed up for early detection of hypertension and acquired renal dysfunction.
Division of Molecular Medicine, St, John's Research Institute, Bangalore, Karnataka, India.
Ashwini
A
Raghavendra
Annes
A
Siji
T S
TS
Sridhar
Kishore
K
Phadke
Anil
A
Vasudevan
D000080924:Aldehyde Dehydrogenase 1 Family; D004252:DNA Mutational Analysis / Q000379:methods* / Q000592:standards; D005312:Fetal Blood; D005820:Genetic Testing / Q000379:methods* / Q000592:standards; D006801:Humans; D007194:India; D007231:Infant, Newborn; D007668:Kidney / Q000002:abnormalities*; D007674:Kidney Diseases / Q000235:genetics* / Q000473:pathology*; D015997:Neonatal Screening / Q000379:methods* / Q000592:standards; D009691:Nucleic Acid Denaturation; D051762:PAX2 Transcription Factor / Q000235:genetics; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics; D012015:Reference Standards; D015203:Reproducibility of Results; D050697:Retinal Dehydrogenase / Q000235:genetics; D012307:Risk Factors
D051762:PAX2 Transcription Factor; C497318:PAX2 protein, human; D000080924:Aldehyde Dehydrogenase 1 Family; C545372:ALDH1A2 protein, human; D050697:Retinal Dehydrogenase; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human